Jeannette Y. Lee

High Impact

Professor

University of Arkansas for Medical Sciences

faculty

Biostatistics, College of Medicine

57 h-index 247 pubs 10,114 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Jeannette Y. Lee is a Professor at the University of Arkansas for Medical Sciences. Her research focuses on the prevention and treatment of cancers and precancerous lesions, particularly in populations disproportionately affected by health disparities. She has investigated the prevalence and prevention of anal high-grade squamous intraepithelial lesions (HSIL) in men who have sex with men living with HIV, exploring the role of human papillomavirus (HPV) vaccination. Dr. Lee's work also includes studies on the treatment of HIV-related lymphomas and the safety and efficacy of various cancer therapies, such as brentuximab vedotin and nivolumab, in individuals living with HIV.

Her research extends to the assessment of serum biomarkers for predicting treatment response in AIDS-associated Kaposi sarcoma and the examination of data processing methods in clinical research through systematic reviews and meta-analyses. Dr. Lee leads a research group and has a significant publication record, with 247 total publications and over 10,000 citations, indicated by an h-index of 57. She has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Jessica Snowden, Songthip Ounpraseuth, Zhuopei Hu, and Milan Bimali.

Metrics

  • h-index: 57
  • Publications: 247
  • Citations: 10,114

Selected Publications

  • Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01) (2025) DOI
  • Comparing Medical Record Abstraction (MRA) error rates in an observational study to pooled rates identified in the data quality literature (2024) DOI
  • Infant Feeding and Weight Trajectories in the Eat, Sleep, Console Trial (2024) DOI
  • Bronchiolitis recovery and the use of High Efficiency Particulate Air (HEPA) Filters (The BREATHE Study): study protocol for a multi-center, parallel, double-blind, randomized controlled clinical trial (2024) DOI
  • Correction: Improving pediatric COVID-19 vaccine uptake using an mHealth tool (MoVeUp): study protocol for a randomized, controlled trial (2024) DOI
  • Error Rates of Data Processing Methods in Clinical Research: A Systematic Review and Meta-Analysis of Manuscripts Identified Through PubMed (2023) DOI
  • Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study (2023) DOI
  • Vitamin D Oral Replacement in Children With Obesity Related Asthma: <scp>VDORA1</scp> Randomized Clinical Trial (2023) DOI
  • Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (Anal Precancer) Among Women With Human Immunodeficiency Virus (2023) DOI
  • Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial (2023) DOI
  • Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087) (2023) DOI
  • Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings (2023) DOI
  • Construct validity and responsiveness of a health-related symptom index for persons either treated or monitored for anal high-grade squamous intraepithelial lesions (HSIL): AMC-A01/-A03 (2023) DOI
  • Comparing Medical Record Abstraction (MRA) Error Rates in an Observational Study to Pooled Rates Identified in the Data Quality Literature (2023) DOI
  • Informatics infrastructure in a rural pediatric clinical trials network: Matching specific clinical research needs with best practices and industry guidelines (2023) DOI

Grants & Funding

  • Sexually Transmitted Infections Clinical Trials Group - BRAVO Study Opt 2 NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham Principal Investigator
  • Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network NIH Co-Principal Investigator
  • No FP attached UAMS College of Medicine Principal Investigator
  • ECHO Administrative Supplement - Neonatal Opioid Trials (ESC Protocol) NIH/Office of the Director - Pass Through: Duke University Principal Investigator
  • AIDS Malignancy Consortium (AMC) Statistical Center - Continuation Year 2022-2023 NIH/Nat. Cancer Institute - Pass Through: Icahn School of Medicine at Mount Sinai Principal Investigator
  • AMC Statistical Center - Latin America Supplement - Continuation Year 2019-2020 - Continuation NIH/Nat. Cancer Institute - Pass Through: University of California, Los Angeles Principal Investigator
  • Statistical Center for the STI CTG NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: University of Alabama at Birmingham Principal Investigator
  • No FP attached UAMS College of Medicine Principal Investigator

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics